MedPath

Effect of combined thermal and neuromuscular stimulations on dysphagia

Not Applicable
Conditions
Condition 1: Stroke. Condition 2: Dysphagia.
Fulfills criteria for stroke in that acute symptoms of focal brain injury that have lasted 24 hours or more (or led to death before 24 hours), but subtype of stroke (ischemic or haemorrhagic) has not been determined by neuroimaging or other techniques.
Difficulty in swallowing which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the pharynx and upper oesophageal sphincter
and oesophageal dy
8B20
MD93
Registration Number
IRCT20190618043938N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Patients were included in the sample if they were in the acute phase of the stroke (the first 30 days after the stroke)
Patients were over 18 years of age and younger than 90 years
Patients suffered from stroke-related dysphagia (in the oral and pharyngeal phases)
Patients had to have a normal level of consciousness

Exclusion Criteria

The patients were unwilling to participate in this study (non-cooperation or non-attendance)
The patients could not collaborate in the swallowing examination because of low consciousness and low comprehension
The recurrence of stroke
Incidence of other neurological disorders that affect dysphagia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Swallowing Disorder. Timepoint: Swallowing disorder is measured by Mann assessment swallowing ability (MASA) test at the beginning of the study (before the start of the study) and 7, 14, 21, 28 and 35 days after the intervention. Method of measurement: Mann assessment swallowing ability (MASA) test.
Secondary Outcome Measures
NameTimeMethod
Oral Movements. Timepoint: Oral movements are measured by the Motility function test at the beginning of the study (before the start of the study) and 7, 14, 21, 28 and 35 days after the intervention. Method of measurement: Motility function test.
© Copyright 2025. All Rights Reserved by MedPath